These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

162 related items for PubMed ID: 1978484

  • 21. Atypical neuroleptics have low affinity for dopamine D2 receptors or are selective for D4 receptors.
    Seeman P, Corbett R, Van Tol HH.
    Neuropsychopharmacology; 1997 Feb; 16(2):93-110; discussion 111-35. PubMed ID: 9015795
    [Abstract] [Full Text] [Related]

  • 22. Remoxipride. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in schizophrenia.
    Wadworth AN, Heel RC.
    Drugs; 1990 Dec; 40(6):863-79. PubMed ID: 1981869
    [Abstract] [Full Text] [Related]

  • 23. In vivo labelling of rat brain dopamine D-2 receptors. Stereoselective blockade by the D-2 antagonist raclopride and its enantiomer of 3H-spiperone, 3H-N,N-propylnorapomorphine and 3H-raclopride binding in the rat brain.
    Köhler C, Karlsson-Boethius G.
    J Neural Transm; 1988 Dec; 73(2):87-100. PubMed ID: 2974879
    [Abstract] [Full Text] [Related]

  • 24. The selective dopamine D2 receptor antagonist raclopride discriminates between dopamine-mediated motor functions.
    Ogren SO, Hall H, Köhler C, Magnusson O, Sjöstrand SE.
    Psychopharmacology (Berl); 1986 Dec; 90(3):287-94. PubMed ID: 2947255
    [Abstract] [Full Text] [Related]

  • 25. Differential regulation of dopamine receptors after chronic typical and atypical antipsychotic drug treatment.
    Tarazi FI, Florijn WJ, Creese I.
    Neuroscience; 1997 Jun; 78(4):985-96. PubMed ID: 9174067
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Effects of dopamine D1 and dopamine D2 antagonists on the free feeding and drinking patterns of rats.
    Clifton PG, Rusk IN, Cooper SJ.
    Behav Neurosci; 1991 Apr; 105(2):272-81. PubMed ID: 1675060
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Extrastriatal dopamine D2 receptors: distribution, pharmacological characterization and region-specific regulation by clozapine.
    Janowsky A, Neve KA, Kinzie JM, Taylor B, de Paulis T, Belknap JK.
    J Pharmacol Exp Ther; 1992 Jun; 261(3):1282-90. PubMed ID: 1534844
    [Abstract] [Full Text] [Related]

  • 30. Conformationally restricted analogues of remoxipride as potential antipsychotic agents.
    Norman MH, Kelley JL, Hollingsworth EB.
    J Med Chem; 1993 Oct 29; 36(22):3417-23. PubMed ID: 7901417
    [Abstract] [Full Text] [Related]

  • 31. Distribution of D1 and D2 dopamine receptors in the basal ganglia of the cat determined by quantitative autoradiography.
    Beckstead RM, Wooten GF, Trugman JM.
    J Comp Neurol; 1988 Feb 01; 268(1):131-45. PubMed ID: 2964456
    [Abstract] [Full Text] [Related]

  • 32. Dopamine receptor subtypes: differential regulation after 8 months treatment with antipsychotic drugs.
    Florijn WJ, Tarazi FI, Creese I.
    J Pharmacol Exp Ther; 1997 Feb 01; 280(2):561-9. PubMed ID: 9023264
    [Abstract] [Full Text] [Related]

  • 33. In vivo labeling of brain dopamine D2 receptors using the high-affinity specific D2 agonist [3H]CV 205-502.
    Closse A, Camps M, Wanner A, Palacios JM.
    Brain Res; 1988 Feb 02; 440(1):123-32. PubMed ID: 2965955
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Involvement of D1 dopamine receptors in the nicotine-induced neuro-endocrine effects and depletion of diencephalic catecholamine stores in the male rat.
    Andersson K, Fuxe K, Eneroth P, Härfstrand A, Agnati LF.
    Neuroendocrinology; 1988 Aug 02; 48(2):188-200. PubMed ID: 2975769
    [Abstract] [Full Text] [Related]

  • 36. [The inhibition of dopamine D1 and D2 receptors in human putamen by antipsychotic drugs].
    Kobayashi T, Shimizu H, Toru M.
    Yakubutsu Seishin Kodo; 1990 Jun 02; 10(2):331-4. PubMed ID: 1979198
    [Abstract] [Full Text] [Related]

  • 37. Potential antipsychotic agents. 7. Synthesis and antidopaminergic properties of the atypical highly potent (S)-5-bromo-2,3-dimethoxy-N-[(1-ethyl-2-pyrrolidinyl)methyl]benzamide and related compounds. A comparative study.
    Högberg T, de Paulis T, Johansson L, Kumar Y, Hall H, Ogren SO.
    J Med Chem; 1990 Aug 02; 33(8):2305-9. PubMed ID: 1973734
    [Abstract] [Full Text] [Related]

  • 38. Remoxipride, a new selective D2 antagonist, and haloperidol in cebus monkeys.
    Gerlach J, Casey DE.
    Prog Neuropsychopharmacol Biol Psychiatry; 1990 Aug 02; 14(1):103-12. PubMed ID: 1967845
    [Abstract] [Full Text] [Related]

  • 39. Synthesis and Pharmacology of the enantiomers of the potential atypical antipsychotic agents 5-OMe-BPAT and 5-OMe-(2,6-di-OMe)-BPAT.
    Homan EJ, Copinga S, Unelius L, Jackson DM, Wikström HV, Grol CJ.
    Bioorg Med Chem; 1999 Jul 02; 7(7):1263-71. PubMed ID: 10465402
    [Abstract] [Full Text] [Related]

  • 40. [3H]-domperidone labels only a single population of receptors which convert from high to low affinity for dopamine in rat brain.
    Grigoriadis D, Seeman P.
    Naunyn Schmiedebergs Arch Pharmacol; 1986 Jan 02; 332(1):21-5. PubMed ID: 2869417
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.